Kaoru Hamada
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Reproductive System and Pregnancy
- T-cell and B-cell Immunology
Papers in
-
- Lung Cancer Diagnosis and Treatment 4
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Cystic Fibrosis Research Advances 3
- Physiology 10
- Asthma and respiratory diseases 6
- Co-authors
- Masayuki Sho (4 shared papers)Yoshiyuki Nakajima (4 shared papers)Miyuki Azuma (2 shared papers)Hideo Yagita∥ (2 shared papers)Takeo Nomi (3 shared papers)Hiromichi Kanehiro (3 shared papers)Koji Enomoto (1 shared paper)Atsushi Kubo (1 shared paper)
- Journals
- Chemotherapy (4 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (2 papers)Transplantation (2 papers)Clinical Cancer Research (2 papers)Kansenshogaku zasshi (12 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Kaoru Hamada
39 papers receiving 2.3k citations
Kaoru Hamada's Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 1.2k
- Immunology 310
- Physiology 257
- Pulmonary and Respiratory Medicine 279
- Otorhinolaryngology 38
Countries citing papers authored by Kaoru Hamada
This map shows the geographic impact of Kaoru Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Hamada more than expected).
Fields of papers citing papers by Kaoru Hamada
This network shows the impact of papers produced by Kaoru Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Hamada. The network helps show where Kaoru Hamada may publish in the future.
Co-authors
The 25 scholars most cited alongside Kaoru Hamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer Hit paper breakdown → | 2007 | 771 |
| 2 | 2005 | 701 | |
| 3 | 1999 | 190 | |
| 4 | 1991 | 105 | |
| 5 | 2007 | 70 | |
| 6 | 2005 | 64 | |
| 7 | 1999 | 48 | |
| 8 | 2007 | 45 | |
| 9 | 2004 | 43 | |
| 10 | 2005 | 42 | |
| 11 | 1999 | 39 | |
| 12 | 1999 | 34 | |
| 13 | 2001 | 32 | |
| 14 | 2009 | 31 | |
| 15 | 1992 | 15 | |
| 16 | Proliferation of erythromycin-stimulated mouse peritoneal macrophages in the absence of exogenous growth factors. | 1994 | 13 |
| 17 | 2005 | 12 | |
| 18 | A 5-lipoxygenase inhibitor, FR110302, suppresses airway hyperresponsiveness and lung eosinophilia induced by Sephadex particles in rats. | 1992 | 11 |
| 19 | 1992 | 8 | |
| 20 | 1989 | 7 |
About Kaoru Hamada
Kaoru Hamada is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Immunology, Epidemiology and Oncology, having authored 41 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (6 papers), Asthma and respiratory diseases (6 papers), Lung Cancer Diagnosis and Treatment (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Lung Cancer Research Studies (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Cystic Fibrosis Research Advances (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (310 citations), Physiology (257 citations), Pulmonary and Respiratory Medicine (279 citations) and Otorhinolaryngology (38 citations). Kaoru Hamada has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Masayuki Sho, Yoshiyuki Nakajima, Miyuki Azuma, Hideo Yagita∥, Takeo Nomi, Hiromichi Kanehiro, Koji Enomoto, Atsushi Kubo, Takahiro Akahori and Hisanori Kashizuka. Their work appears in journals such as Chemotherapy, American Journal of Physiology-Lung Cellular and Molecular Physiology, Transplantation, Clinical Cancer Research and Kansenshogaku zasshi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.